Technology · India Bureau
Tech executive warns scientists gambling on AI cancer cure while smoking
A senior technology officer at major data analytics firm Palantir has cautioned that researchers may be adopting risky personal health behaviours based on optimistic assumptions about artificial intelligence's future medical capabilities.
LSN India ·
Shya Shankar, Chief Technology Officer at Palantir Technologies, has raised concerns about researchers potentially engaging in unhealthy habits such as smoking while betting on breakthrough artificial intelligence treatments for cancer in coming years.
Shankar's remarks, made during a recent interview, highlight a troubling disconnect between speculative technological optimism and present-day health decisions. The CTO suggested that some in the scientific community may be rationalising current risky behaviours by assuming that advanced AI systems will eventually develop cures for cancer-related illnesses.
The observation underscores broader questions about how emerging technologies influence decision-making in the scientific and research communities. While artificial intelligence has shown promise in various medical applications, from diagnostic imaging to drug discovery, such capabilities remain largely experimental and their timeline uncertain.
Shankar's warning serves as a cautionary note about the dangers of letting speculative future breakthroughs overshadow evidence-based health practices today. Public health experts have long emphasised that smoking remains one of the most significant preventable risk factors for multiple cancers, regardless of technological advancements on the horizon.
The remarks also reflect deeper concerns within the tech and science sectors about balancing genuine innovation optimism with responsible present-day decision-making among researchers and professionals.